MetaCap

Acurx Pharmaceuticals (ACXP) vs Bullfrog AI (BFRG)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Bullfrog AI is the larger company by market cap ($6.6 million vs $6.3 million), about 1.1 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ACXP-20.00%BFRG-49.82%
+2%-25%-52%
Oct 7, 20261 yearNov 20, 2026
ACXP-18.11%BFRG-44.95%
+2%-22%-47%
Oct 5, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ACXP versus BFRG key metrics
MetricACXPBFRG
Share price$1.04$0.3556
Market cap$6.30M$6.65M
1-day change+0.97%-8.84%
YTD return—-59.73%
1-year return—-58.21%
EPS (TTM)$-1.90$-0.41
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)—$116.67K
Net income (latest FY)$-7.97M$-6.50M
Gross margin—18.76%
Operating margin—-5652.38%
Net margin—-5569.61%
52-week high$7.54$1.96
52-week low$0.90$0.35
Distance from 52-week high-86.21%-81.86%
Analyst consensusstrong_buynone
Avg. price target upside+1534.62%—
Average volume97.29K5.38M
Shares outstanding6.06M18.69M
Employees49
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Acurx Pharmaceuticals

ACXP stock →

Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections in the United States. The company's lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that is in Phase 2b clinical trial to treat patients with clostridium difficile infections.

Health Care · Biotechnology: Pharmaceutical Preparations · 4 employees

About Bullfrog AI

BFRG stock →

Bullfrog AI Holdings, Inc. operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States.

Health Care · Biotechnology: Pharmaceutical Preparations · 9 employees

ACXP vs BFRG FAQ

Which is bigger, Acurx Pharmaceuticals or Bullfrog AI?

Bullfrog AI (BFRG) is larger, with a market capitalization of $6.65M compared with $6.30M for Acurx Pharmaceuticals (ACXP).

Are Acurx Pharmaceuticals and Bullfrog AI in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons